Skip to content

Pulmonx Corp

LUNG

CIK 0001127537

← back to feed
Revenue (TTM)
$88.49M
+8.0% YoY Q1 Apr 2026
Net Income (TTM)
−$57.23M
+4.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.41
+7.6% YoY Q1 Apr 2026
Gross Margin
74.2%
Q1 Apr 2026
Operating Margin
-64.1%
Q1 Apr 2026
Net Margin
-64.7%
Q1 Apr 2026
Free Cash Flow (TTM)
−$48.58M
Q1 Apr 2026
Cash
$61.57M
Q1 Apr 2026
Total Debt
$37.31M
Q1 Apr 2026
Shares Outstanding
42.24M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings